All the latest news and information on the cannabis and psychedelics industries, with updates from the UK and across the globe.
In the latest edition of the Volteface podcast Paul charts with Dr. Giulia Zampini about the recently launched People and Dancefloors research project and have a heated discussion on …
The coronavirus pandemic has seen an increase in recreational cannabis use perhaps due to lockdown boredom, anxiety, loneliness or lack of stimulation. This increase in use of the substance …
In Volteface’s first documentary, Director Paul North takes a trip to Brighton to catch up with Carly Barton, who was the first patient to legally receive medical cannabis in …
Belgium, June 2019: I am convicted along with nineteen other pioneers, based on the 1921 drug law. As a doctor in medical science, researcher, nurse and former humanitarian aid …
The New Leaf Opportunities campaign has today made two major announcements including news that CBD company Ciitech has joined the campaign as a partner. The company joins the campaign …
Despite a year of mixed blessings, there have been significant positive developments in the Cannabis world, paving a promising if bumpy road ahead for 2021 What has happened this …
Volteface is pleased to announce the launch of ‘New Leaf Opportunity’, a campaign focusing on the economic benefits, innovations and investment opportunities that medical cannabis and CBD can bring …
Views on the normalisation of cannabis in society is firmly dependent on social interactions, who you are talking to, and their relationship with it. There will be some in society …
Yesterday, history was made with the UN reclassifying cannabis. This removes cannabis from the list of most dangerous narcotics, recognising its medical value. The decision was voted on by …
There are estimated to be 1.4 million patients in the UK who are eligible for a medical cannabis prescription. However, 73% of these patients are unable to afford one. …
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept